Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
30/05/2025
Kingsoft Corporation: First quarter revenue of 2.34 billion yuan.
Latest
2 m ago
The federal district court of the District of Columbia in the United States follows the previous ruling of the United States Court of International Trade. In addition, a second court in the United States has dismissed a lawsuit filed by Trump against a toy company regarding tariffs.
3 m ago
An American judge has stated that he will order the government to indefinitely maintain Harvard University's student visa program.
6 m ago
Omkar Rai: Maintain rating on C3.ai (AI.US) from outperform to outperform, target price adjusted from $56.00 to $45.00.
8 m ago
Owen Haemer: Maintain a rating of outperform for Y-mAbs Therapeutics (YMAB.US), adjusted from outperforming the market to outperforming the market, with a target price adjusted from $20.00 to $15.00.
9 m ago
Auburn Hammurabi: Maintains a rating of InflaRx (IFRX.US), adjusted from outperform to outperform rating, with a target price adjusted from $6.00 to $3.00.
See all latest